Skip to content

iRadimed IRMD Free cash flow yield

Free cash flow yield at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
4.7%
Merit Medical Systems logo
Merit Medical SystemsMMSI
5.4%+2.5pp
ICU Medical logo
ICU MedicalICUI
2.9%-1.0pp
ITG
Integer HoldingsITGR
3.3%+0.6pp
RadNet logo
RadNetRDNT
2.5%+0.4pp
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
0.5%

Other financials

Income statement

See full
Revenue$22.0M+12.6%
Gross profit$16.8M+13.3%
Operating income$7.2M+33.2%
Net income$5.8M+24.1%
EPS (diluted)$0.45+21.6%

Balance sheet

See full
Cash & equivalents$56.4M+12.0%
Total debt$59.2K-96.9%
Total equity$98.5M+9.4%
Total assets$114.4M+12.4%

Cash flow

See full
Operating cash flow$8.3M+93.2%
CapEx$403.0K-89.1%
Free cash flow$7.9M+1,226%

Valuation

See full
Market cap$1.21B+63.4%
P/E51.3×+13.8×
P/S14×+4.2×

Profitability

See full
Gross margin76.8%-0.1pp
Operating margin32.4%+2.3pp
Net margin27.4%+1.0pp
FCF margin28.4%+8.9pp

Returns & leverage

See full
Return on equity25%+1.2pp
Debt / equity0.0×
Current ratio7.1×-1.7×

Where this comes from

Calculated from iRadimed’s reported figures.

Based on trailing twelve months.

The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRadimed's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRadimed's free cash flow yield?
iRadimed (IRMD) reported free cash flow yield of 2% in Q1 2026.
How has iRadimed's free cash flow yield changed year-over-year?
iRadimed's free cash flow yield decreased by 9.1% year-over-year, from 2.2% to 2%.
What is the long-term trend for iRadimed's free cash flow yield?
Over 5 years (2020 to 2025), iRadimed's free cash flow yield has grown at a -6.2% compound annual growth rate (CAGR), from 1.9% to 1.4%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.